Entry Detail



General Information

Database ID:exR0015570
RNA Name:TUBA1A
RNA Type:mRNA
Chromosome:chr12
Starnd:-
Coordinate:
Start Site(bp):49184795End Site(bp):49189080
External Links:ENSG00000167552



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC124312.1
chr15
24955034
25000276
+
ACSS2
chr20
34872146
34927962
+
ADA2
chr22
17178790
17258235
-
AC120057.2
chr17
7240427
7244635
-
AHCY
chr20
34280268
34311802
-
AC093525.2
chr16
2496032
2520218
+
ADORA2A
chr22
24417879
24442357
+
AC005832.4
chr12
4604944
4662643
+
AC048338.1
chr12
122207779
122266423
-
AIF1
chr6
31615217
31617021
+
ABHD4
chr14
22598237
22613215
+
ALDH3A2
chr17
19648136
19685760
+
ACTB
chr7
5527148
5563784
-
AFDN
chr6
167826922
167972023
+
AC092073.1
chr19
34396315
34409364
+
AC092143.1
chr16
89919165
89936092
+
ALDOA
chr16
30064164
30070457
+
AAR2
chr20
36236459
36270918
+
ACTR2
chr2
65227753
65271253
+
ABCF1
chr6
30571393
30597179
+
AC245033.1
chr15
82536788
82573194
-
AC010422.3
chr19
12643831
12648397
-
ADM
chr11
10305073
10307397
+
ACBD5
chr10
27195214
27242130
-
ABCA7
chr19
1039997
1065572
+
AKAP17A
chrX
1591604
1602520
+
ACTR3
chr2
113890063
113962596
+
ACTG1
chr17
81509971
81523847
-
AGRN
chr1
1020120
1056118
+
AC005943.1
chr19
1578339
1605445
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-367-3p
chr4
112647877
112647898
-
hsa-miR-198
chr3
120395703
120395724
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002116.1
chr19
36008638
36014235
-
AC016876.2
chr17
7581964
7584086
-
AC020928.1
chr19
36773112
36777078
+
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC106864.1
chr4
112693047
112706810
-
AC132217.1
chr11
2129121
2129964
-
AC133644.3
chr2
87455476
87767359
+
AD000090.1
chr19
35557956
35581954
+
AF106564.1
chr8
24912165
24914717
-
AL021707.2
chr22
38667585
38681847
-
AL049795.2
chr1
32170733
32176568
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.